Evidence map›Paper›PMID 34179541›Full record

ReviewHeliyon2021

The roles of machine learning methods in limiting the spread of deadly diseases: A systematic review.

Rayner Alfred, Joe Henry Obit

Abstract readReview
In one paragraph

Review in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Socioeconomic Interventions for WHO's End TB Strategy Targets: Insights from SIR Modelling in Kazakhstan.International journal of environmental research and public health · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. A Deep Learning Approach for Dengue Fever Prediction in Malaysia Using LSTM with Spatial Attention.International journal of environmental research and public health · 2023
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rayner AlfredKnowledge Technology Research Unit, Faculty of Computing and Informatics, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia.
Joe Henry ObitKnowledge Technology Research Unit, Faculty of Computing and Informatics, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine learning (ML) methods can be leveraged to prevent the spread of deadly infectious disease outbreak (e.g., COVID-19). This can be done by applying machine learning methods in predicting and detecting the deadly infectious disease. Most reviews did not discuss about the machine learning algorithms, datasets and performance measurements used for various applications in predicting and detecting the deadly infectious disease. In contrast, this paper outlines the literature review based on two major ways (e.g., prediction, detection) to limit the spread of deadly disease outbreaks. Hence, this study aims to investigate the state of the art, challenges and future works of leveraging ML methods to detect and predict deadly disease outbreaks according to two categories mentioned earlier. Specifically, this study provides a review on various approaches (e.g., individual and ensemble models), types of datasets, parameters or variables and performance measures used in the previous works. The literature review included all articles from journals and conference proceedings published from 2010 through 2020 in Scopus indexed databases using the search terms

Indexed as

DetectionDisease outbreakInfectious diseaseMachine learningPrediction

Identifiers

PMID34179541
PMCPMC8219638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.